AlloVir, Inc. (ALVR) SEC filings
ALVR SEC filings moved a median of +0.11% by the close. ALVR SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ALVR overview →
66 measured ALVR SEC filing events.
Where these ALVR SEC filings landedvs 30 measured ALVR SEC filing reactions
| Middle 50% of ALVR SEC filing reactions | -2.27% to +2.93% |
|---|---|
| Median reaction (to close) | +0.11% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 ALVR SEC filing events with a measured close landed between -2.27% and +2.93%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Kalaris Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form 8-K Kalaris Therapeutics, For: Aug 11 | SEC filing · Form 8-K | — | — | |
| Form 8-K Kalaris Therapeutics, For: Jul 14 | SEC filing · Form 8-K | — | — | |
| Form 8-K Kalaris Therapeutics, For: Jul 17 | SEC filing · Form 8-K | — | — | |
| Form 8-K Kalaris Therapeutics, For: Jul 03 | SEC filing · Form 8-K | — | — | |
| Form 8-K Kalaris Therapeutics, For: Jun 03 | SEC filing · Form 8-K | — | — | |
| Form 10-Q Kalaris Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 8-K Kalaris Therapeutics, For: May 12 | SEC filing · Form 8-K | — | — | |
| Form ARS Kalaris Therapeutics, For: Dec 31 | SEC filing · Form ARS | — | — | |
| Form DEF 14A Kalaris Therapeutics, For: Jun 03 | SEC filing · Form DEF | — | — | |
| Form DEFA14A Kalaris Therapeutics, | SEC filing · Form DEFA14A | — | — | |
| Form EFFECT Kalaris Therapeutics, | SEC filing · Form EFFECT | — | — | |
| Form 8-K Kalaris Therapeutics, For: Apr 08 | SEC filing · Form 8-K | — | — | |
| Form S-3 Kalaris Therapeutics, | SEC filing · Form S-3 | — | — | |
| Form 10-K Kalaris Therapeutics, For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 8-K Kalaris Therapeutics, For: Mar 17 | SEC filing · Form 8-K | — | — | |
| Form S-8 Kalaris Therapeutics, | SEC filing · Form S-8 | — | — | |
| Form 8-K Kalaris Therapeutics, For: Mar 09 | SEC filing · Form 8-K | — | — | |
| Form 8-K Kalaris Therapeutics, For: Dec 17 | SEC filing · Form 8-K | — | — | |
| Form 8-K Kalaris Therapeutics, For: Dec 17 | SEC filing · Form 8-K | — | — | |
| Form 10-Q Kalaris Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 8-K Kalaris Therapeutics, For: Nov 12 | SEC filing · Form 8-K | — | — | |
| Form 8-K Kalaris Therapeutics, For: Oct 28 | SEC filing · Form 8-K | — | — | |
| Form 10-Q Kalaris Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form 8-K Kalaris Therapeutics, For: Aug 12 | SEC filing · Form 8-K | — | — | |
| Form 8-K Kalaris Therapeutics, For: Aug 13 | SEC filing · Form 8-K | — | — | |
| Form ARS Kalaris Therapeutics, For: Dec 31 | SEC filing · Form ARS | — | — | |
| Form DEF 14A Kalaris Therapeutics, For: Aug 12 | SEC filing · Form DEF | — | — | |
| Form DEFA14A Kalaris Therapeutics, | SEC filing · Form DEFA14A | — | — | |
| Form 8-K Kalaris Therapeutics, For: Jun 19 | SEC filing · Form 8-K | — | — | |
| Form S-8 Kalaris Therapeutics, | SEC filing · Form S-8 | — | — | |
| Form 10-Q Kalaris Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 8-K Kalaris Therapeutics, For: May 14 | SEC filing · Form 8-K | — | — | |
| Form 8-K Kalaris Therapeutics, For: Apr 10 | SEC filing · Form 8-K | — | — | |
| Form 8-K Kalaris Therapeutics, For: Apr 03 | SEC filing · Form 8-K | — | — | |
| Form 8-K Kalaris Therapeutics, For: Mar 18 | SEC filing · Form 8-K | — | — | |
| Form SEC STAFF LETTER Allovir, Inc. | SEC filing · Form SEC | +4.14% | -5.69% | |
| Form 8-K Allovir, Inc. For: Mar 12 | SEC filing · Form 8-K | +4.14% | -5.69% | |
| Form 10-K Allovir, Inc. For: Dec 31 | SEC filing · Form 10-K | — | +2.39% | |
| Form EFFECT Allovir, Inc. | SEC filing · Form EFFECT | +0.00% | -2.20% | |
| Form S-4/A Allovir, Inc. | SEC filing · Form S-4 | -1.86% | -1.28% | |
| Form S-4/A Allovir, Inc. | SEC filing · Form S-4 | +0.00% | -2.29% | |
| Form 8-K Allovir, Inc. For: Jan 15 | SEC filing · Form 8-K | -3.94% | +4.17% | |
| Form 8-K Allovir, Inc. For: Jan 09 | SEC filing · Form 8-K | +0.04% | -0.39% | |
| Form 8-K Allovir, Inc. For: Dec 19 | SEC filing · Form 8-K | +1.15% | +7.01% | |
| Form S-4 Allovir, Inc. | SEC filing · Form S-4 | -1.02% | +0.22% | |
| Form DEF 14A Allovir, Inc. For: Jan 09 | SEC filing · Form DEF | -5.71% | -3.99% | |
| Form PRE 14A Allovir, Inc. For: Nov 26 | SEC filing · Form PRE | -0.76% | +3.01% | |
| Form 10-Q Allovir, Inc. For: Sep 30 | SEC filing · Form 10-Q | +3.70% | +4.33% | |
| Form 8-K Allovir, Inc. For: Nov 07 | SEC filing · Form 8-K | -5.70% | -12.82% | |
| Form 10-Q Allovir, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.16% | -3.11% | |
| Form 8-K Allovir, Inc. For: Jul 01 | SEC filing · Form 8-K | +1.91% | +0.00% | |
| Form 8-K Allovir, Inc. For: Jun 05 | SEC filing · Form 8-K | -1.00% | -1.25% | |
| Form 8-K Allovir, Inc. For: Jun 06 | SEC filing · Form 8-K | +4.69% | -1.18% | |
| Form 8-K Allovir, Inc. For: May 31 | SEC filing · Form 8-K | +0.00% | +2.91% | |
| Form 10-Q Allovir, Inc. For: Mar 31 | SEC filing · Form 10-Q | +4.79% | +6.48% | |
| Form ARS Allovir, Inc. For: Dec 31 | SEC filing · Form ARS | +0.00% | +0.68% | |
| Form DEF 14A Allovir, Inc. For: Jun 06 | SEC filing · Form DEF | +0.00% | +0.68% | |
| Form DEFA14A Allovir, Inc. | SEC filing · Form DEFA14A | +0.00% | +0.68% | |
| Form 10-K Allovir, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.69% | +12.82% | |
| Form RW Allovir, Inc. | SEC filing · Form RW | -1.43% | +2.94% | |
| Form 8-K Allovir, Inc. For: Feb 09 | SEC filing · Form 8-K | -1.18% | -1.79% | |
| Form 8-K Allovir, Inc. For: Jan 01 | SEC filing · Form 8-K | -4.19% | -4.18% | |
| Form 8-K Allovir, Inc. For: Dec 22 | SEC filing · Form 8-K | +3.56% | +2.05% | |
| Form 10-Q Allovir, Inc. For: Sep 30 | SEC filing · Form 10-Q | +4.29% | -4.00% | |
| Form 8-K Allovir, Inc. For: Nov 02 | SEC filing · Form 8-K | +1.25% | +9.38% |
Keep exploring
More ALVR: earnings → · analyst actions → · ALVR overview →